Second cord blood transplantation and interferon-α maintenance therapy for relapsed Ph+ acute lymphoblastic leukemia with the T315I mutation

Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant

(2016) Daniela Renzi et al.   CHEMOTHERAPY

Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients

(2016) Vaclava Polivkova et al.   PLoS One

Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies

(2015) Swati Naik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Interferon-α: A Potentially Effective Treatment for Minimal Residual Disease in Acute Leukemia/Myelodysplastic Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation

(2015) Xiao-Dong Mo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

(2015) Farhad Ravandi et al.   CANCER

The role of ponatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia

(2015) David S Sanford et al.   Expert Review of Anticancer Therapy

Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the fr

(2013) Simona Soverini et al.   CANCER

Induction of sustained deep molecular response in a patient with chronic-phase T315I-mutated chronic myeloid leukemia with interferon-α monotherapy

(2013) Mette Ilander et al.   LEUKEMIA & LYMPHOMA

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

(2013) J.E. Cortes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Second allogeneic hematopoietic SCT for relapsed ALL in children

(2012) M Kato et al.   BONE MARROW TRANSPLANTATION

Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa

(2012) Hidehiro Itonaga et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Successful treatment of relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia with T315I mutation after haplo-identical hematopoietic stem cell transplantation with donor lymphocyte transfusion and interferon-α-2b

(2009) Ying Wang et al.   LEUKEMIA RESEARCH

Successful treatment with interferon-α-2b and imatinib in an adult Japanese male with Philadelphia chromosome-positive acute lymphoblastic leukemia and minimal residual disease following allogeneic transplantation

(2008) M Sumi et al.   BONE MARROW TRANSPLANTATION